Condition
Adenocarcinoma - Gastroesophageal Junction (GEJ)
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (2)
Trial Status
Recruiting1
Terminated1
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07359443Phase 1Recruiting
Combination of Chemotherapy and Adaptive MR-Guided Radiotherapy to Improve Outcomes in Patients With Esophageal Adenocarcinoma
NCT07260461Not ApplicableNot Yet Recruiting
The Efficacy and Safety of Laparoscopic Proximal Gastrectomy With LPG-tbROSF Versus LTG for Localized Proximal Gastric Cancer.
NCT06299163Phase 1Terminated
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
Showing all 3 trials